1. Home
  2. BCAB vs ARKR Comparison

BCAB vs ARKR Comparison

Compare BCAB & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ARKR
  • Stock Information
  • Founded
  • BCAB 2007
  • ARKR 1983
  • Country
  • BCAB United States
  • ARKR United States
  • Employees
  • BCAB N/A
  • ARKR N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ARKR Restaurants
  • Sector
  • BCAB Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • BCAB 31.5M
  • ARKR 25.3M
  • IPO Year
  • BCAB 2020
  • ARKR N/A
  • Fundamental
  • Price
  • BCAB $0.68
  • ARKR $6.96
  • Analyst Decision
  • BCAB Hold
  • ARKR
  • Analyst Count
  • BCAB 3
  • ARKR 0
  • Target Price
  • BCAB $1.00
  • ARKR N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • ARKR 6.4K
  • Earning Date
  • BCAB 11-06-2025
  • ARKR 08-11-2025
  • Dividend Yield
  • BCAB N/A
  • ARKR N/A
  • EPS Growth
  • BCAB N/A
  • ARKR N/A
  • EPS
  • BCAB N/A
  • ARKR N/A
  • Revenue
  • BCAB $11,000,000.00
  • ARKR $171,834,000.00
  • Revenue This Year
  • BCAB N/A
  • ARKR N/A
  • Revenue Next Year
  • BCAB N/A
  • ARKR N/A
  • P/E Ratio
  • BCAB N/A
  • ARKR N/A
  • Revenue Growth
  • BCAB N/A
  • ARKR N/A
  • 52 Week Low
  • BCAB $0.24
  • ARKR $6.38
  • 52 Week High
  • BCAB $2.53
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 63.71
  • ARKR 42.40
  • Support Level
  • BCAB $0.60
  • ARKR $6.81
  • Resistance Level
  • BCAB $0.84
  • ARKR $7.22
  • Average True Range (ATR)
  • BCAB 0.08
  • ARKR 0.15
  • MACD
  • BCAB 0.02
  • ARKR 0.05
  • Stochastic Oscillator
  • BCAB 62.14
  • ARKR 34.09

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: